Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (Adults and Pediatrics)

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy	DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome, viral infectious disease	Recruiting	Phase 3	2026-09-02		NCT03394365

Clinical trials